Handelsinvest Investeringsforvaltning’s Agios Pharmaceuticals AGIO Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-29,000	Closed	-$940K	–	117
2019 Q3	$940K	Hold	29,000	–	–	0.21%	81
2019 Q2	$1.45M	Hold	29,000	–	–	0.3%	67
2019 Q1	$1.96M	Hold	29,000	–	–	0.43%	56
2018 Q4	$1.34M	Hold	29,000	–	–	0.33%	63
2018 Q3	$2.24M	Hold	29,000	–	–	0.46%	53
2018 Q2	$2.44M	Hold	29,000	–	–	0.54%	49
2018 Q1	$2.37M	Hold	29,000	–	–	0.53%	47
2017 Q4	$1.66M	Hold	29,000	–	–	0.37%	55
2017 Q3	$1.94M	Hold	29,000	–	–	0.46%	47
2017 Q2	$1.49M	Buy	+29,000	New	+$1.48M	0.38%	55

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's AGIO Position: Q4 2019 in Review

Handelsinvest Investeringsforvaltning sold out of Agios Pharmaceuticals (AGIO) in Q4 2019, closing a stake of 29,000 shares — an estimated $940K sold.

Handelsinvest Investeringsforvaltning first reported a position in AGIO in Q2 2017 and held it in 10 quarters. The position peaked at $2.44M in Q2 2018. 199 funds tracked by Wall St. Rank hold AGIO as of Q4 2019.

Handelsinvest Investeringsforvaltning reported no remaining Agios Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 29,000 Agios Pharmaceuticals shares in Q4 2019, an estimated $940K.
Handelsinvest Investeringsforvaltning first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 10 quarters.
Handelsinvest Investeringsforvaltning's Agios Pharmaceuticals position peaked at $2.44M in Q2 2018.
199 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2019.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2019, filed 30 Jan 2020.